{"id":394015,"date":"2020-12-07T06:33:10","date_gmt":"2020-12-07T11:33:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=394015"},"modified":"2020-12-07T06:33:10","modified_gmt":"2020-12-07T11:33:10","slug":"khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/","title":{"rendered":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<ul type=\"disc\">\n<li>Khiron applauds <span class=\"xn-location\">Colombia<\/span> on becoming one of the first countries to extend national health insurance for patients to include medical cannabis as a first line therapy <\/li>\n<li>Leveraging Khiron&#8217;s status as a National Strategic Project, Khiron medical cannabis products and clinic services are now covered by health insurance companies in <span class=\"xn-location\">Colombia<\/span><\/li>\n<li>Over 94% of Colombians have health insurance policies <\/li>\n<li>More than 1,000 Khiron prescriptions issued in the last quarter have already qualified for this insurance coverage, removing economic barriers and increasing patient access to the Company&#8217;s products and services <\/li>\n<li>The Government of <span class=\"xn-location\">Colombia<\/span> has included THC and CBD products in its health insurance directive following an analysis of efficacy and quality of legal medical cannabis and the market potential <\/li>\n<\/ul>\n<p>\n        <span class=\"xn-location\">TORONTO<\/span>, <span class=\"xn-chron\">Dec. 7, 2020<\/span> \/PRNewswire\/ &#8211;\u00a0Khiron Life Sciences Corp. (&#8220;Khiron&#8221; or the &#8220;Company&#8221;) (TSXV: KHRN), (OTCQX: KHRNF), (<span class=\"xn-location\">Frankfurt<\/span>: A2JMZC), a vertically integrated cannabis leader with core operations in <span class=\"xn-location\">Latin America<\/span> and <span class=\"xn-location\">Europe<\/span>, announces that as a result of strong clinical evidence, the Company&#8217;s National Strategic Project status, and a directive from the Government of <span class=\"xn-location\">Colombia<\/span>, its medical cannabis products and clinic services are now covered by the country&#8217;s major health insurance providers, including medical cannabis as a first line therapy. In <span class=\"xn-location\">Colombia<\/span> more than 94% of the population have health insurance.\u00a0 <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\" title=\"Khiron Life Sciences Corp. Logo (CNW Group\/Khiron Life Sciences Corp.)\" alt=\"Khiron Life Sciences Corp. Logo (CNW Group\/Khiron Life Sciences Corp.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;We see the inclusion of our products and services under health insurance policies as a significant driver of revenue opportunities for Khiron in <span class=\"xn-location\">Colombia<\/span>, and a validation of our clinic model and the potential for market growth in the country. Importantly, this will allow more Colombians access to benefit from our medical cannabis products and clinic resources,&#8221; commented <span class=\"xn-person\">Alvaro Torres<\/span>, Khiron CEO and Director.<\/p>\n<p>&#8220;Since becoming the first company to fill cannabis prescriptions in <span class=\"xn-location\">Colombia<\/span>, 92% of our patients have reported an improvement in their primary conditions after four months of treatment with Khiron products. \u00a0We\u00a0look forward to improving the quality of life of even more patients who are now able to access medical cannabis through insurance coverage,&#8221; added Mr. Torres.<\/p>\n<p>With today&#8217;s news, <span class=\"xn-location\">Colombia<\/span> joins an exclusive list of countries offering health insurance coverage for medical cannabis, including <span class=\"xn-location\">Germany<\/span> and the <span class=\"xn-location\">Czech Republic<\/span>. In the first half of 2020, over \u20ac75 million worth of medical cannabis products were sold in <span class=\"xn-location\">Germany<\/span> to an estimated patient population of approximately 120,000 (Source: Prohibition Partners). Revisions to German laws in 2017 had wide ranging implications for the country&#8217;s cannabis market requiring health insurers to cover the costs of the prescription except in exceptional circumstances, with over 60% of patients receiving reimbursement from their health insurance provider. In the <span class=\"xn-location\">Czech Republic<\/span>, which recently included extended health insurance for medical cannabis, sales in the first four months of 2020 increased threefold over the same period in 2019. <\/p>\n<p>Under the Colombian program, Khiron clinics receive government and insurance company authorization to fill patient prescriptions for magistral preparations; subsequently, the Company is reimbursed once products have been dispensed to the patients. This will allow a greater number of Colombian patients to have access to Khiron&#8217;s medical cannabis products and clinical services. Khiron&#8217;s clinic strategy continues to<b>\u00a0<\/b>provide cost-effective access to patients, while allowing the Company to generate medical evidence and deliver an unparalleled physician and patient experience. With a large patient base and growing network of physicians trained in the prescription of medical cannabis, Khiron is uniquely positioned to take advantage of the insurance policy change.<\/p>\n<p>\n        <b>About Khiron Life Sciences Corp.<br \/><\/b>Khiron is a vertically integrated medical and CPG cannabis company with core operations in <span class=\"xn-location\">Latin America<\/span>, and operational activity in <span class=\"xn-location\">Europe<\/span> and <span class=\"xn-location\">North America<\/span>. Khiron is the leading cannabis company in <span class=\"xn-location\">Colombia<\/span> and the first company licensed in <span class=\"xn-location\">Colombia<\/span> for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in <span class=\"xn-location\">Peru<\/span> and has a presence in <span class=\"xn-location\">Mexico<\/span>, <span class=\"xn-location\">Uruguay<\/span>, UK, <span class=\"xn-location\">Spain<\/span> and also in <span class=\"xn-location\">Germany<\/span>, where it is positioned to begin sales of medical cannabis.<\/p>\n<p>Leveraging its first-mover advantage and patient-oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in <span class=\"xn-location\">Colombia<\/span>, with Kuida<sup>TM<\/sup> now marketed in multiple jurisdictions in <span class=\"xn-location\">Latin America<\/span>, the US and UK. The Company is led by Co-founder and Chief Executive Officer, <span class=\"xn-person\">Alvaro Torres<\/span>, together with an experienced and diverse executive team and Board of Directors.<\/p>\n<p>Visit Khiron online at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3003802-1&amp;h=4257154909&amp;u=https%3A%2F%2Finvestors.khiron.ca%2Fcorporate-information&amp;a=investors.khiron.ca\" rel=\"nofollow noopener noreferrer\">investors.khiron.ca<\/a> and on Instagram @khironlife.<\/p>\n<p>Cautionary Notes<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release may contain certain &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron&#8217;s control, including the risk factors discussed in Khiron&#8217;s Annual Information Form which is available on Khiron&#8217;s SEDAR profile at <a href=\"http:\/\/www.sedar.com\" rel=\"nofollow\">www.sedar.com<\/a>. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.<\/p>\n<p>Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=TO14617&amp;sd=2020-12-07\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia-301187052.html\">http:\/\/www.prnewswire.com\/news-releases\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia-301187052.html<\/a><\/p>\n<p>SOURCE  Khiron Life Sciences Corp.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=TO14617&amp;Transmission_Id=202012070630PR_NEWS_USPR_____TO14617&amp;DateId=20201207\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Khiron applauds Colombia on becoming one of the first countries to extend national health insurance for patients to include medical cannabis as a first line therapy Leveraging Khiron&#8217;s status as a National Strategic Project, Khiron medical cannabis products and clinic services are now covered by health insurance companies in Colombia Over 94% of Colombians have health insurance policies More than 1,000 Khiron prescriptions issued in the last quarter have already qualified for this insurance coverage, removing economic barriers and increasing patient access to the Company&#8217;s products and services The Government of Colombia has included THC and CBD products in its health insurance directive following an analysis of efficacy and quality of legal medical cannabis and the market potential &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-394015","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Khiron applauds Colombia on becoming one of the first countries to extend national health insurance for patients to include medical cannabis as a first line therapy Leveraging Khiron&#8217;s status as a National Strategic Project, Khiron medical cannabis products and clinic services are now covered by health insurance companies in Colombia Over 94% of Colombians have health insurance policies More than 1,000 Khiron prescriptions issued in the last quarter have already qualified for this insurance coverage, removing economic barriers and increasing patient access to the Company&#8217;s products and services The Government of Colombia has included THC and CBD products in its health insurance directive following an analysis of efficacy and quality of legal medical cannabis and the market potential &hellip; Continue reading &quot;Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T11:33:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia\",\"datePublished\":\"2020-12-07T11:33:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/\"},\"wordCount\":994,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1359483\\\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/\",\"name\":\"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1359483\\\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\",\"datePublished\":\"2020-12-07T11:33:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1359483\\\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1359483\\\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/","og_locale":"en_US","og_type":"article","og_title":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk","og_description":"PR Newswire Khiron applauds Colombia on becoming one of the first countries to extend national health insurance for patients to include medical cannabis as a first line therapy Leveraging Khiron&#8217;s status as a National Strategic Project, Khiron medical cannabis products and clinic services are now covered by health insurance companies in Colombia Over 94% of Colombians have health insurance policies More than 1,000 Khiron prescriptions issued in the last quarter have already qualified for this insurance coverage, removing economic barriers and increasing patient access to the Company&#8217;s products and services The Government of Colombia has included THC and CBD products in its health insurance directive following an analysis of efficacy and quality of legal medical cannabis and the market potential &hellip; Continue reading \"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T11:33:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia","datePublished":"2020-12-07T11:33:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/"},"wordCount":994,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/","name":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg","datePublished":"2020-12-07T11:33:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1359483\/Khiron_Life_Sciences_Corp__Khiron_Medical_Cannabis_Products_Now.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-medical-cannabis-products-now-qualify-for-national-insurance-coverage-in-colombia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=394015"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394015\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=394015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=394015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=394015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}